Clearbridge Health to acquire 65% stake in medical centre in Manila

Clearbridge Health to acquire 65% stake in medical centre in Manila

Stanislaus Jude Chan
04/01/18, 07:03 pm

SINGAPORE (Jan 4): Clearbridge Health’s wholly-owned subsidiary, Clearbridge Health (Philippines), has entered into a conditional share purchase agreement to acquire 65% of the common shares in the issued share capital of Marzan Health Care Inc for 69.6 million Philippine pesos ($1.9 million).

The target company operates a medical centre offering a wide range of services including pathology services, imaging diagnostics, dental care, as well as dialysis and renal care in Manila, Philippines.

Following the completion of the proposed acquisition, Clearbridge says it also intends to enter into a subscription agreement to subscribe to cumulative, non-voting, redeemable preferred shares in Marzan at 1.00 peso per share, for a total subscription price of 25 million pesos.

Subject to approval of the Philippines Securities Exchange Commission, the proposed subscription will see Clearbridge holding 100% of the preferred shares in Marzan.

The proposed transactions will be funded via proceeds from Clearbridge’s initial public offering (IPO) and bank borrowings.

Clearbridge says the proposed transactions will provide the group with a platform to expand its business in the Philippines.

Marzan also holds the required licences to provide a wide range of medical services in the Philippines, which would allow Clearbridge to accelerate its expansion in the country.

In addition, the group says it expects to be able to leverage on Marzan’s existing distribution network to deliver the group's precision medicine products and services.

Clearbridge earlier disclosed it had entered into a term sheet for the potential acquisition in the offer document for its IPO in December.

See: Clearbridge Health to list on Catalist; seeking to raise $24.6 million

“The Philippines remains a vastly untapped market for the provision of precision medical healthcare services. We see huge potential for Clearbridge to establish a strong foothold in the precision medicine space on the back of rising affluence amongst a significant segment of the populace,” says Jeremy Yee, executive director and chief executive officer of Clearbridge.

Shares of Clearbridge closed 1.5 cents higher, or up 3.8%, at 41 cents on Thursday.

Next stop: The interchange of public and private good

SINGAPORE (May 20): Two-minute intervals between trains. Fewer breakdowns. Clean, new buses running at a higher frequency. Bright LED screens displaying details of stops on both buses and trains. To many commuters who are enjoying these benefits, the meltdown of Singapore’s transport system in December 2011, and again in July 2015, is a distant memory. Certainly, services have improved significantly. There are new trains and buses, while existing ones have been spiffed up. There has been an overhaul of the older rail systems, presumably including fixing the grips for the electricity rail ....
Moving from compliance to accountability

While the collection, use and disclosure of data is regulated by the Personal Data Protection Act, b

Failed Innopac deal portends mining magnate Gutnick’s woes in Australia

SINGAPORE (May 20): The Australian Securities and Investments Commission (ASIC) is seeking judicial permission to wind down mining company Merlin Diamonds. The regulator is also probing into whether its chairman Joseph Gutnick failed in his duties. Gutnick, who is known as “Diamond Joe”, is under investigation for a A$13 million ($12.3 million) loan made by Merlin to AXIS Consultants, a private company linked to him. Merlin shares have been suspended from trading since October 2018. ASIC is seeking an order to appoint Deloitte to liquidate Merlin, owner of the Merlin Diamond Mine Pro....